Federated Hermes
KMTS

Federated Hermes’s Kestra Medical Technologies KMTS Stock Holding History

Federated Hermes’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4M Hold
525,000
– – 0.02% 598
2026
Q1 		$10.5M Hold
525,000
– – 0.02% 620
2025
Q4 		$13.9M Buy
525,000
+125,000
+31% +$3.22M 0.02% 544
2025
Q3 		$9.5M Hold
400,000
– – 0.02% 576
2025
Q2 		$6.63M Hold
400,000
– – 0.01% 659
2025
Q1 		$9.97M Buy
+400,000
New +$9.19M 0.02% 559

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Federated Hermes's KMTS Position: Q2 2026 in Review

Federated Hermes held its Kestra Medical Technologies (KMTS) position steady in Q2 2026 at 525,000 shares worth $13.4M. The position accounts for 0.02% of the portfolio, ranked #598.

Federated Hermes first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.9M in Q4 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Federated Hermes held 525,000 shares of Kestra Medical Technologies worth $13.4M as of Q2 2026.
  • Federated Hermes left its Kestra Medical Technologies share count unchanged in Q2 2026.
  • Kestra Medical Technologies made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #598 holding.
  • Federated Hermes first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Federated Hermes's Kestra Medical Technologies position peaked at $13.9M in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.